Dermata Therapeutics's total assets for Q1 2026 were $7.47M, a decrease of -5.06% from the previous quarter. DRMA total liabilities were $1.05M for the fiscal quarter, a -35.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.